<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical manifestations and diagnosis of fibromuscular dysplasia
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical manifestations and diagnosis of fibromuscular dysplasia
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical manifestations and diagnosis of fibromuscular dysplasia
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeffrey W Olin, DO
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            George L Bakris, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John P Forman, MD, MSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 04, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fibromuscular dysplasia (FMD) is a noninflammatory, nonatherosclerotic disorder that leads to arterial stenosis, occlusion, aneurysm, dissection, and arterial tortuosity. These findings have been observed in nearly every arterial bed [
         <a href="#rid1">
          1
         </a>
         ]. The most frequently involved arteries are the renal and internal carotid arteries, followed by the vertebral, visceral, and external iliac arteries [
         <a href="#rid1">
          1,2
         </a>
         ]. Disease presentation may vary widely, depending upon the arterial segment involved and the severity of disease.
        </p>
        <p>
         The epidemiology, pathogenesis, clinical manifestations, and diagnosis of FMD in adults are reviewed here. The treatment of FMD and the general evaluation for possible renovascular hypertension and stroke are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3826.html" rel="external">
          "Treatment of fibromuscular dysplasia of the renal arteries"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3825.html" rel="external">
          "Establishing the diagnosis of renovascular hypertension"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3862.html" rel="external">
          "Evaluation of secondary hypertension"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1134.html" rel="external">
          "Clinical diagnosis of stroke subtypes"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1083.html" rel="external">
          "Overview of the evaluation of stroke"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with FMD have involvement of the renal arteries approximately 75 to 80 percent of the time and involvement of the extracranial cerebrovascular arteries (eg, carotid and vertebral arteries) approximately 75 percent of the time [
         <a href="#rid2">
          2
         </a>
         ]. Approximately two-thirds of patients have multiple arteries involved [
         <a href="#rid1">
          1,3-5
         </a>
         ].
        </p>
        <p>
         Among adults, FMD is more common among females. In most large series, approximately 90 percent of cases are in females. There does
         <strong>
          not
         </strong>
         appear to be a female predominance among children with FMD [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         In the past, it was believed that FMD was a disease of young females. However, older individuals account for a large proportion of affected patients in several cohorts. As an example, in the United States FMD Registry, the mean age at diagnosis was 52 years, with a range of 5 to 97 years [
         <a href="#rid2">
          2,8,9
         </a>
         ].
        </p>
        <p>
         There is often a delay from the first symptom or sign until the diagnosis of FMD [
         <a href="#rid7">
          7,10
         </a>
         ]. In one study, for example, the average age of hypertension diagnosis in patients with focal FMD was 26 years, but the average age of diagnosis was 30 years [
         <a href="#rid10">
          10
         </a>
         ]. In another study of multifocal FMD, the average age of hypertension onset was 40 years and the average age of diagnosis of FMD was 49 years [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Renal arteries
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among patients with renovascular hypertension, FMD accounts for 35 to 50 percent of cases in children and 5 to 10 percent of cases in adults under the age of 60 years [
         <a href="#rid11">
          11-13
         </a>
         ]. It can also occur in older patients, either in isolation or in combination with atherosclerosis, but the prevalence is not well described. Approximately 65 percent of patients with renal artery FMD also have carotid or vertebral FMD, and, similarly, patients with carotid or vertebral FMD are likely to have kidney involvement [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6087.html" rel="external">
          "Definition and diagnosis of hypertension in children and adolescents"
         </a>
         .)
        </p>
        <p>
         FMD of the renal arteries can be an incidental finding. In a synthesis of four angiographic studies, for example, 139 of 3181 asymptomatic potential kidney donors (4.4 percent) had evidence for FMD [
         <a href="#rid14">
          14
         </a>
         ]. The prevalence of incidentally discovered FMD was even higher in the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial [
         <a href="#rid15">
          15
         </a>
         ]. Although FMD was an exclusion criterion for enrollment in this trial, and all patients presumably had atherosclerotic renal artery stenosis, review of images by the core laboratory revealed that FMD was present in 8.8 percent of the 499 females who were enrolled and 2.8 percent of the 498 males who were enrolled [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Other arteries
         </span>
         <span class="headingEndMark">
          —
         </span>
         Extracranial cerebrovascular (eg, carotid and vertebral arteries) involvement is common in patients with established renal FMD. Data from the first 447 patients entered into the United States FMD Registry reveal that approximately 65 percent have extracranial cerebrovascular disease [
         <a href="#rid2">
          2
         </a>
         ]. Older literature indicated that carotid artery involvement was present in only 25 to 30 percent of patients with FMD [
         <a href="#rid16">
          16
         </a>
         ]. However, it was not previously standard practice to image other vascular beds when renal artery FMD was diagnosed, possibly accounting for these historical lower-prevalence estimates. Asymptomatic extracranial cerebrovascular disease is discovered more commonly now that every patient diagnosed with renal artery FMD routinely undergoes imaging of other vascular beds.
        </p>
        <p>
         When cerebrovascular disease is present, there is often bilateral carotid involvement, coexisting vertebral artery disease, and, less commonly, disease in the external carotid, middle cerebral, anterior cerebral, basilar, and anterior communicating arteries [
         <a href="#rid2">
          2,17,18
         </a>
         ]. FMD may also be associated with intracranial aneurysms [
         <a href="#rid17">
          17-21
         </a>
         ].
        </p>
        <p>
         FMD of the visceral arteries is less common and typically involves the celiac, superior mesenteric, inferior mesenteric, hepatic, and splenic arteries. In the lower extremities, FMD occurs most frequently in the external iliac arteries, although it also has been described in the femoral, popliteal, and tibioperoneal arteries [
         <a href="#rid16">
          16,22
         </a>
         ]. Now that radial artery access is being performed more frequently for patients undergoing percutaneous coronary intervention, FMD is being identified more frequently in the brachial, radial, and ulnar arteries [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLASSIFICATION (BY ANGIOGRAPHY)
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the past, FMD was classified according to the arterial layer affected (intima, media, or adventitia) [
         <a href="#rid24">
          24,25
         </a>
         ]. However, pathological specimens are rarely obtained (due to the fact that, if a lesion requires treatment, percutaneous endovascular therapy is the preferred method rather than surgery). Thus, because FMD is virtually always diagnosed radiographically and histology is not typically available, pathological classification has been replaced by an angiographic classification  (
         <a class="graphic graphic_table graphicRef54161" href="/z/d/graphic/54161.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         FMD is most commonly classified by angiographic appearance  (
         <a class="graphic graphic_table graphicRef54161" href="/z/d/graphic/54161.html" rel="external">
          table 1
         </a>
         ). There are two angiographic subtypes of FMD:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multifocal FMD (more common)  (
         <a class="graphic graphic_diagnosticimage graphicRef100114" href="/z/d/graphic/100114.html" rel="external">
          image 1
         </a>
         ) has the angiographic appearance of a "string of beads." Multifocal FMD corresponds pathologically to medial fibroplasia, the most common histologic type, and to perimedial fibroplasia, which is less common.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Focal FMD (less common)  (
         <a class="graphic graphic_diagnosticimage graphicRef100116" href="/z/d/graphic/100116.html" rel="external">
          image 2
         </a>
         ) has the angiographic appearance of a "circumferential or tubular stenosis" and corresponds pathologically to intimal fibroplasia. Medial hyperplasia and periarterial hyperplasia are histologic types that may also have a focal appearance.
        </p>
        <p>
        </p>
        <p>
         It has been shown that these two different angiographic subtypes of FMD (multifocal and focal) have different phenotypic presentations and natural history [
         <a href="#rid10">
          10
         </a>
         ]. This has led some investigators to question whether FMD is, in fact, a single disease [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         FMD is
         <strong>
          not
         </strong>
         classified histologically because pathological specimens are rarely obtained [
         <a href="#rid1">
          1
         </a>
         ]. In the past, fibrous lesions were classified according to the arterial layer affected (intima, media, or adventitia)  (
         <a class="graphic graphic_table graphicRef54161" href="/z/d/graphic/54161.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medial fibroplasia represents the most common dysplastic lesion, accounting for more than 80 percent of fibromuscular lesions [
         <a href="#rid24">
          24,25
         </a>
         ]. Angiographically, medial fibroplasia is characterized by the classic "string of beads" appearance  (
         <a class="graphic graphic_diagnosticimage graphicRef100114" href="/z/d/graphic/100114.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef141209" href="/z/d/graphic/141209.html" rel="external">
          image 3
         </a>
         ). This appearance is due to alternating fibromuscular webs followed by poststenotic dilatation. In areas of dilatation, the internal elastic lamina is absent, which is possibly the primary defect. Total occlusion is uncommon in the absence of dissection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intimal fibroplasia (which accounts for approximately 10 percent of FMD) is caused by circumferential or eccentric deposition of collagen in the intima  (
         <a class="graphic graphic_diagnosticimage graphicRef100116" href="/z/d/graphic/100116.html" rel="external">
          image 2
         </a>
         ). The internal elastic lamina may be intact, fragmented, or duplicated, the latter especially in the childhood form. There is no inflammatory or lipid component.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In perimedial fibroplasia, which occurs predominately in children, large parts of the media (in particular, the outer zone) are replaced by collagen, with irregular thickening of the media. Total occlusion may occur with development of collateral vasculature. "Beading" is present in this type, but the "beads" are less numerous and are smaller than in medial fibroplasia. Aneurysm formation is uncommon.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medial hyperplasia, a rare manifestation, is caused by smooth muscle cell hyperplasia without fibrosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Periarterial hyperplasia, also a rare manifestation, is caused by expansion of the fibrous adventitia; collagen extends into the periarterial fat, with accompanying inflammation.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The etiology of FMD remains unknown. Although a variety of factors have been implicated, most investigators now believe that genetics play an important role in the development of FMD [
         <a href="#rid1">
          1,27
         </a>
         ], with some studies reporting an autosomal mode of inheritance with variable penetrance [
         <a href="#rid28">
          28,29
         </a>
         ]. Another study found an association between FMD and a single nucleotide variant in the phosphatase and actin regulator 1 gene (
         <em>
          PHACTR1
         </em>
         ) [
         <a href="#rid30">
          30
         </a>
         ]. This variant, rs9349379, is also a risk locus for coronary artery disease, migraine headache, cervical artery dissection [
         <a href="#rid31">
          31
         </a>
         ], and spontaneous coronary artery dissection (SCAD) [
         <a href="#rid32">
          32
         </a>
         ]. Using whole-exome sequencing, targeted sequencing, and genome sequences in patients with FMD or SCAD, genetic variants in prostaglandin I2 receptor gene (
         <em>
          PTGIR
         </em>
         ) that impair its cellular function were identified that may play a role in the pathogenesis. A limitation of this study is that the prevalence of the identified
         <em>
          PTGIR
         </em>
         loss-of-function variants is low and affects a small fraction of patients with FMD and SCAD [
         <a href="#rid33">
          33
         </a>
         ]. FMD exhibits a plasma proteogenomic and lipid signature that includes potential causative factors, such as CD2-associated protein. This is promising for the development of a blood test for the diagnosis of FMD [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Given the predominance in females of childbearing age, hormonal influences are thought to also be important in the pathogenesis of FMD, yet there are no definitive studies. It is also possible that mechanical factors such as stretching of smooth muscle cells and trauma to the blood vessel wall may initiate the changes seen in FMD, but this theory has never been proven.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disease manifestations may result from the following mechanisms [
         <a href="#rid4">
          4,5
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ischemia related to stenosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dissection and occlusion of major arteries (renal infarction, stroke, myocardial infarction)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rupture of aneurysms
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Embolization of intravascular thrombi from dissection or aneurysms
        </p>
        <p>
        </p>
        <p>
         Thus, disease presentation may vary widely, depending upon the arterial segment involved, the length and degree of stenosis, and the angiographic type of FMD.
        </p>
        <p class="headingAnchor" id="H122907093">
         <span class="h2">
          Common presenting symptoms and signs
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical presentation of FMD varies somewhat in males as compared with females [
         <a href="#rid35">
          35
         </a>
         ]. In general, manifestations of renal FMD (eg, hypertension, flank pain) are more likely to occur in males, as are arterial dissections and aneurysms. By contrast, manifestations of cerebrovascular FMD (eg, headache, pulsatile tinnitus, neck pain, carotid bruit) are more likely to occur in females.
        </p>
        <p>
         The most common presenting symptoms in 615 individuals from the United States FMD Registry are as follows [
         <a href="#rid35">
          35
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Headache – 57 percent (58 percent of females and 47 percent of males)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pulsatile tinnitus – 33 percent (36 percent of females and 9 percent of males)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neck pain – 27 percent (29 percent of females and 13 percent of males)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flank or abdominal pain – 17 percent (14 percent of females and 44 percent of males)
        </p>
        <p>
        </p>
        <p>
         The most common presenting signs of FMD are as follows [
         <a href="#rid35">
          35
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypertension – 67 percent (66 percent of females and 74 percent of males)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cervical bruit – 25 percent (27 percent of females and 4 percent of males)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abdominal bruit – 11 percent (12 percent of females and no males)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transient ischemic attack – 10 percent (10 percent of females and 4 percent of males)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stroke – 8 percent (8 percent of females and 4 percent of males)
        </p>
        <p>
        </p>
        <p>
         Headache, pulsatile tinnitus, and neck pain are typically symptoms of extracranial cerebrovascular FMD  (
         <a class="graphic graphic_table graphicRef120138" href="/z/d/graphic/120138.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid36">
          36
         </a>
         ], usually caused by stenosis, aneurysm rupture, dissection, or cerebral thromboembolism [
         <a href="#rid20">
          20,21,37-39
         </a>
         ]. Other manifestations suggestive of brain ischemia may occur, including amaurosis fugax, Horner syndrome, and, as noted above, transient ischemic attack or stroke [
         <a href="#rid17">
          17,18
         </a>
         ]. Brain ischemia is almost always related to a dissection of the carotid or vertebral artery.
        </p>
        <p>
         Hypertension is the most common manifestation of renal artery FMD  (
         <a class="graphic graphic_table graphicRef120137" href="/z/d/graphic/120137.html" rel="external">
          table 3
         </a>
         ). A decrease in kidney perfusion activates the renin-angiotensin-aldosterone system, which has direct effects on sodium excretion, sympathetic nerve activity, intrarenal prostaglandin concentrations, and nitric oxide production. These ultimately lead to renovascular hypertension. Flank pain and abdominal pain can result from ischemia, aneurysm rupture, or dissection of renal and mesenteric arteries, respectively.
        </p>
        <p>
         Chronic mesenteric ischemia or intestinal angina may occur when two of the splanchnic arteries are occluded and the third is severely stenotic. Occasionally, mesenteric ischemia may occur with superior mesenteric artery stenosis alone, although extensive collaterals in the mesenteric circulation generally prevent ischemia when only one splanchnic vessel is occluded. Patients may present with the classic triad of postprandial abdominal pain, weight loss, and an epigastric bruit. In rare cases, the stenosis progresses to total occlusion, resulting in acute intestinal ischemia [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2293858809">
         <span class="h3">
          Less common manifestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with lower-extremity FMD may present with intermittent claudication, critical limb ischemia, or microembolism that manifests as painful, cyanotic toes [
         <a href="#rid22">
          22
         </a>
         ]. Rarely, iliac dissection, occlusion, or aneurysm rupture may occur [
         <a href="#rid41">
          41
         </a>
         ]. In the upper extremities, FMD may present with weakness, paresthesias, upper-extremity claudication, or critical limb ischemia [
         <a href="#rid23">
          23
         </a>
         ]. Physical examination may reveal diminished pulses, a bruit, and cyanosis.
        </p>
        <p>
         FMD may also be asymptomatic or, in its extreme form, may present as a multisystem disease mimicking necrotizing vasculitis [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3399148089">
         <span class="h3">
          Aneurysm and dissection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with FMD have a high prevalence of aneurysm and/or dissection prior to or at the time of FMD diagnosis [
         <a href="#rid1">
          1,7,37
         </a>
         ]. In 921 patients from the United States registry for FMD, aneurysm occurred in 200 patients (22 percent) and dissection in 237 (26 percent). Overall, 384 patients (42 percent) had an aneurysm and/or dissection among this cohort  (
         <a class="graphic graphic_figure graphicRef116302" href="/z/d/graphic/116302.html" rel="external">
          figure 1
         </a>
         ). In our center, among 146 patients who had repeated carotid duplex ultrasound exams and among all patients who had cross-sectional imaging from the head to the pelvis, the prevalence of both aneurysm and dissection was 36 percent [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
         The most common locations for aneurysms are the renal artery (34 percent), carotid artery (31 percent), and intracranial arteries (22 percent). Less frequently, the mesenteric arteries, vertebral arteries, and aorta are involved [
         <a href="#rid19">
          19,37
         </a>
         ].
        </p>
        <p>
         In patients who presented with dissections, the most commonly involved arteries were the carotid artery (64 percent), vertebral artery (21 percent), renal artery (11 percent), and coronary artery (10 percent). Less frequently, the aorta, mesenteric artery, and iliac arteries were involved [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         The majority of patients (50 to 75 percent) who experience spontaneous coronary artery dissection (SCAD) have FMD identified in another arterial circulation [
         <a href="#rid43">
          43-48
         </a>
         ]. It is not uncommon for SCAD to be misdiagnosed as atherosclerosis in females with few or no cardiovascular risk factors [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         The recognition that patients with FMD have a high prevalence of arterial aneurysm and dissection has led to the recommendation that every patient diagnosed with FMD should have one-time, head-to-pelvic cross-sectional imaging [
         <a href="#rid1">
          1
         </a>
         ]. Similar recommendations have been made for patients with SCAD [
         <a href="#rid50">
          50
         </a>
         ]. The preferred imaging strategy is computed tomography angiography (CTA), and magnetic resonance angiography (MRA) is an alternative. If CTA is performed, we prefer CTA of the neck and head on one day followed one week later by CTA of the chest, abdomen, and pelvis [
         <a href="#rid37">
          37,51,52
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H122907100">
         <span class="h2">
          When to suspect fibromuscular dysplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         FMD should be suspected in the following settings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a patient with hypertension (particularly in a woman under the age of 60 years) who has findings that would prompt an evaluation for secondary hypertension or renovascular disease, including  (
         <a class="graphic graphic_table graphicRef56130" href="/z/d/graphic/56130.html" rel="external">
          table 4
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/3862.html" rel="external">
          "Evaluation of secondary hypertension"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe or resistant hypertension
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Onset of hypertension before the age of 35 years
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A sudden rise in blood pressure over a previously stable baseline
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A significant increase in the serum creatinine concentration (≥0.5 to 1 mg/dL [44 to 88 micromol/L]) that occurs after the institution of therapy with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) in the absence of an excessive reduction in blood pressure
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An epigastric/abdominal bruit
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presence of a carotid bruit in a patient under the age of 60 years, especially if other common risk factors for atherosclerosis, aside from hypertension, are absent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe and persistent headache or pulsatile tinnitus that has no other obvious explanation or is accompanied by focal neurologic symptoms or signs. (See
         <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">
          "Evaluation of headache in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6855.html" rel="external">
          "Etiology and diagnosis of tinnitus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transient ischemic attack or stroke in a woman under the age of 60 years, especially if other common risk factors for atherosclerosis, aside from hypertension, are absent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dissection of a peripheral (carotid, vertebral, renal) or coronary artery (ie, SCAD). (See
         <a class="medical medical_review" href="/z/d/html/97665.html" rel="external">
          "Spontaneous coronary artery dissection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aneurysm in a visceral, carotid, vertebral, or intracranial vessel.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aortic aneurysm in a patient younger than 60 years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subarachnoid hemorrhage.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal infarction.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          DIAGNOSIS OF FIBROMUSCULAR DYSPLASIA
         </span>
        </p>
        <p class="headingAnchor" id="H469037107">
         <span class="h2">
          Confirming the diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with suspected FMD, the diagnosis is confirmed by diagnostic imaging that reveals consistent findings (see
         <a class="local">
          'Classification (by angiography)'
         </a>
         above). A noninvasive imaging test is usually performed first. Invasive angiography is performed in patients if there is a high clinical suspicion of FMD, and treatment with revascularization is planned if a stenosis is found. A negative angiogram excludes a diagnosis of FMD in the vascular bed that was imaged. (See
         <a class="local">
          'Choice of diagnostic imaging'
         </a>
         below.)
        </p>
        <p>
         Because FMD has a propensity to occur in multiple vascular beds, and because patients with FMD have a high prevalence of arterial aneurysm and dissection, every patient diagnosed with FMD should undergo one-time, head-to-pelvic, cross-sectional imaging [
         <a href="#rid1">
          1,53
         </a>
         ].
        </p>
        <p>
         As noted above, the angiographic appearance of FMD falls into the following classes  (
         <a class="graphic graphic_table graphicRef54161" href="/z/d/graphic/54161.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Classification (by angiography)'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multifocal FMD – Imaging may reveal a beaded appearance to the affected artery (ie, "string of beads")  (
         <a class="graphic graphic_diagnosticimage graphicRef100114" href="/z/d/graphic/100114.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef141209" href="/z/d/graphic/141209.html" rel="external">
          image 3
         </a>
         ). Most commonly, beads are numerous and are larger than the diameter of the vessel. Less commonly (typically in children with FMD), beads are few and are smaller than the diameter of the vessel.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Focal FMD – Imaging may reveal a concentric, smooth, band-like focal stenosis or a tubular stenosis  (
         <a class="graphic graphic_diagnosticimage graphicRef100116" href="/z/d/graphic/100116.html" rel="external">
          image 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         In addition to the multifocal arterial beading or focal stenosis that can occur with FMD, patients with FMD may have extreme arterial tortuosity. This is most common in the carotid, vertebral, and coronary arteries  (
         <a class="graphic graphic_diagnosticimage graphicRef101255" href="/z/d/graphic/101255.html" rel="external">
          image 4
         </a>
         ), and occurs more frequently in patients with FMD than in age- and sex-matched controls [
         <a href="#rid49">
          49,54
         </a>
         ]. This tortuosity is not specific for FMD, and its consequence in patients with FMD is unknown.
        </p>
        <p>
         Histopathology (and histologic classification) is
         <strong>
          no longer
         </strong>
         part of the diagnosis. Histopathology of FMD lesions is performed only in the rare patient who requires surgical revascularization or resection of an aneurysm.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Choice of diagnostic imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         FMD is most frequently diagnosed using noninvasive imaging tests [
         <a href="#rid1">
          1,55-59
         </a>
         ], specifically computed tomography angiography (CTA), magnetic resonance angiography (MRA), or duplex ultrasonography, and less frequently by catheter-based angiography.
        </p>
        <p>
         Choosing a noninvasive imaging technique depends upon the expertise of a given institution but is also influenced by the vascular bed that is presumed to be involved. While duplex ultrasound is an excellent technique for the carotid, vertebral, and renal arteries, it has the lowest spatial resolution of all of the cross-sectional imaging modalities, has the most operator dependence, and should be used as the first choice only in high-volume centers with extensive expertise in this technique [
         <a href="#rid1">
          1
         </a>
         ]. Thus, while there are some centers who use duplex ultrasound as initial screening, for most centers, either CTA or MRA would be a better diagnostic choice. CTA is preferable due to higher spatial resolution than MRA, less dependence upon technical expertise, and a shorter scan time [
         <a href="#rid1">
          1
         </a>
         ]. In addition, MRA may miss FMD if the FMD is mild.
        </p>
        <p>
         Although noninvasive imaging techniques are usually sufficient to diagnose FMD, catheter-based angiography, which is the reference standard, can improve visualization of the arteries by eliminating background soft tissue and bone and has higher spatial resolution than any of the other imaging modalities [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         When performed, angiography can also be used to measure the pressure gradient across the stenosis; a pressure decrease threshold (using a pressure wire) of 10 percent or more of the mean pressure should be used to decide whether a lesion is hemodynamically significant [
         <a href="#rid1">
          1,5,60
         </a>
         ]. In addition, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can be helpful in determining if a dissection or intramural hematoma is present as well as help to determine if angioplasty has improved the stenosis.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Computed tomography angiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multirow detector CTA has excellent diagnostic accuracy for FMD of the main renal arteries, although the sensitivity decreases when FMD is only present in the smaller branch renal arteries. In one study, in which CTA reconstructions (including multiplanar reformatted images, maximum intensity projections, and axial images) were evaluated in patients with known FMD, CTA detected FMD lesions in 100 percent of 37 arteries studied [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         Multirow detector CT scanners, which offer more rapid image acquisition, variable section thickness, three-dimensional rendering, diminished helical artifacts, and smaller contrast requirements, may gain an increased role in the diagnosis and follow-up of renal artery FMD [
         <a href="#rid58">
          58,59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Magnetic resonance angiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRA offers inconsistent detection of FMD and is performed if CTA is contraindicated [
         <a href="#rid5">
          5,56,61
         </a>
         ]. In one series, for example, the sensitivity was only 22 percent [
         <a href="#rid56">
          56
         </a>
         ]. The spatial resolution in the branch vessels is not adequate, and artifact may occur, suggesting "beading" when none is present. However, MRA can be useful for detecting aneurysms and dissections.
        </p>
        <p class="headingAnchor" id="H573238510">
         <span class="h3">
          Duplex ultrasonography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Duplex ultrasound can detect elevated blood flow velocities in the mid and distal portions of the renal artery and internal carotid arteries, the most common locations for FMD [
         <a href="#rid4">
          4,55
         </a>
         ]. Ultrasound results are most helpful if they report an increased peak systolic velocity, turbulent blood flow, and tortuosity of the mid and distal artery. Reports that assign a percent diameter stenosis of the artery are less helpful since such statements are usually inaccurate. In general, duplex ultrasonography should be used for diagnosis of FMD only in high-volume centers with expertise in this technique or if CTA and MRA cannot be performed [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Duplex of the extracranial cerebrovascular arteries may also be useful in patients with FMD if the ultrasonographer can image the most distal portion of the carotid and vertebral arteries up to the point where they enter the skull base  (
         <a class="graphic graphic_diagnosticimage graphicRef141209" href="/z/d/graphic/141209.html" rel="external">
          image 3
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The conditions that most commonly mimic the presentation of FMD are atherosclerotic vascular disease and vasculitis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Both atherosclerosis and FMD may cause renal artery stenosis and carotid artery disease. Patients with atherosclerosis are usually older and have typical cardiovascular risk factors such as dyslipidemia, diabetes mellitus, and a history of tobacco use, whereas individuals with FMD are usually younger and have fewer cardiovascular risk factors [
         <a href="#rid16">
          16
         </a>
         ]. However, given that FMD can occur in older patients, age alone does not exclude the diagnosis. The oldest patient in the US Registry for FMD is 97 years old.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Atherosclerosis usually involves the ostial or proximal segment of the arteries, whereas FMD involves the middle or distal segment. In addition, the "string of beads" appearance is unique to FMD. Thus, atherosclerotic disease and FMD can typically be distinguished radiographically.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multisystem involvement is observed in both vasculitis and FMD. Unlike patients with a vasculitic process, those with FMD generally will not have associated anemia, thrombocytopenia, or abnormalities of acute phase reactants (eg, erythrocyte sedimentation rate or C-reactive protein), given that it is a noninflammatory process. An exception might be in the setting of an acute infarction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other possibilities that may be initially considered before renal artery FMD is diagnosed include primary hypertension (formerly called "essential" hypertension) and any of the potential causes of secondary hypertension. When appropriate, an evaluation for secondary causes of hypertension should identify the presence of FMD. These issues are discussed elsewhere:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3862.html" rel="external">
          "Evaluation of secondary hypertension"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3852.html" rel="external">
          "Overview of hypertension in adults", section on 'History'
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3852.html" rel="external">
          "Overview of hypertension in adults", section on 'Testing for secondary hypertension'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          MONITORING DISEASE PROGRESSION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The patient who is being treated medically (eg, not eligible for or refusing intervention) should have monitoring of the blood pressure response to antihypertensive therapy and serum creatinine levels every three months initially, and, if the blood pressure stabilizes, annual exams may then be performed. The decision against revascularization may need to change if hypertension is treatment resistant or if there is progressive loss of kidney function. (See
         <a class="medical medical_review" href="/z/d/html/3826.html" rel="external">
          "Treatment of fibromuscular dysplasia of the renal arteries", section on 'Antihypertensive therapy'
         </a>
         .)
        </p>
        <p>
         Noninvasive imaging tests, such as duplex ultrasound, should be obtained every 6 to 12 months. Since radiation exposure is high, computed tomography angiography (CTA) should only be repeated if there is a strong clinical suspicion regarding the progression of the disease. If the patient has an aneurysm, they can be followed with magnetic resonance angiography (MRA) to follow the size of the aneurysm. However, assessing disease progression by angiographic criteria may be difficult, especially with multifocal FMD, where it is not possible to determine the degree of stenosis.
        </p>
        <p>
         Some reports suggest that disease progression may be better monitored by measuring the kidney parenchyma. Compared with patients who have primary hypertension (formerly called "essential" hypertension), patients with unilateral renal FMD had significantly decreased mean cortical thickness and reduced kidney length as determined by CT [
         <a href="#rid62">
          62
         </a>
         ]. In the contralateral, unaffected kidney, cortical thickness was also markedly decreased, although kidney length was preserved. Atrophic changes in the kidney parenchyma by ultrasound generally represent chronic ischemic damage and are not reversed after renal revascularization [
         <a href="#rid63">
          63
         </a>
         ]. It is uncommon to lose kidney parenchyma from multifocal FMD in the absence of a renal artery dissection; however, focal FMD is often associated with a dramatic decrease in kidney size and is progressive, ultimately leading to occlusion of the vessel [
         <a href="#rid5">
          5,26
         </a>
         ].
        </p>
        <p>
         Most clinicians who care for a large number of patients with FMD believe that multifocal FMD is a nonprogressive disease. In a study evaluating the likelihood of progression, 146 patients with multifocal carotid artery FMD who had more than one carotid duplex ultrasound over a 12-year period were included. The mean follow-up was 35 months (range 5 to 153 months), and the mean number of carotid duplex ultrasounds were 4 (range 1 to 17). No patient developed FMD in a
         <strong>
          new
         </strong>
         arterial bed (ie, one that was not initially involved), and progression did not occur in the arteries that were involved at the first evaluation. Three patients experienced a dissection, and two of these patients had a previous dissection [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H900952534">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/139162.html" rel="external">
          "Society guideline links: Fibromuscular dysplasia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fibromuscular dysplasia (FMD) is a noninflammatory, nonatherosclerotic disorder that leads to arterial stenosis, occlusion, aneurysm, dissection, and arterial tortuosity. It has been observed in nearly every arterial bed. The most frequently involved arteries are the renal (75 to 80 percent of patients), internal carotid, and vertebral arteries (approximately 75 percent of patients have carotid and/or vertebral involvement), followed by visceral and external iliac arteries. Among adults, FMD is more common among females (approximately 90 percent of cases are in females). There does not appear to be a female predominance among children with FMD. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         FMD is virtually always diagnosed radiographically, and histology is not typically available. Thus, angiographic classification has replaced the historic histologic classification  (
         <a class="graphic graphic_table graphicRef54161" href="/z/d/graphic/54161.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Classification (by angiography)'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Multifocal FMD (more common)  (
         <a class="graphic graphic_diagnosticimage graphicRef100114" href="/z/d/graphic/100114.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef141209" href="/z/d/graphic/141209.html" rel="external">
          image 3
         </a>
         ) has the angiographic appearance of a "string of beads." Multifocal FMD corresponds pathologically to medial fibroplasia, the most common histologic type, and to perimedial fibroplasia, which is less common.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Focal FMD (less common)  (
         <a class="graphic graphic_diagnosticimage graphicRef100116" href="/z/d/graphic/100116.html" rel="external">
          image 2
         </a>
         ) has the angiographic appearance of a "circumferential or tubular stenosis" and corresponds pathologically to intimal fibroplasia. Medial hyperplasia and periarterial hyperplasia are histologic types that may also have a focal appearance.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most common presenting signs and symptoms of FMD include hypertension, headache, pulsatile tinnitus, neck pain, and cervical bruit. Other presenting signs and symptoms can include flank or abdominal pain, an abdominal bruit, transient ischemic attack, and stroke. These disease manifestations may result from ischemia related to stenosis, dissection, and occlusion of arteries, rupture of aneurysms, or embolization of intravascular thrombi. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         FMD should be suspected in the following settings (see
         <a class="local">
          'When to suspect fibromuscular dysplasia'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a patient with hypertension (particularly in a woman under the age of 60 years) who has findings that would prompt an evaluation for secondary hypertension or renovascular disease  (
         <a class="graphic graphic_table graphicRef56130" href="/z/d/graphic/56130.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The presence of a carotid bruit in a patient under the age of 60 years, especially if other common risk factors for atherosclerosis, aside from hypertension, are absent.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe and persistent headache or pulsatile tinnitus that has no other obvious explanation or is accompanied by focal neurologic symptoms or signs.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transient ischemic attack or stroke in a woman under the age of 60 years, especially if other common risk factors for atherosclerosis, aside from hypertension, are absent.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dissection of a peripheral or coronary artery (ie, spontaneous coronary artery dissection [SCAD]).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Aneurysm of a visceral, carotid, vertebral, or intracranial artery.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Aortic aneurysm in a patient under 60 years of age.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with suspected FMD, the diagnosis is confirmed by diagnostic imaging that reveals consistent findings. A noninvasive imaging test is usually performed first (ie, computed tomography angiography [CTA], magnetic resonance angiography [MRA], or, in some centers with sufficient expertise, duplex ultrasound). Catheter-based angiography is performed in patients if there is a high clinical suspicion of FMD, and treatment with revascularization is planned if a stenosis is found. A negative angiogram excludes a diagnosis of FMD in the vascular bed that was imaged. (See
         <a class="local">
          'Diagnosis of fibromuscular dysplasia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Because patients with FMD have a high prevalence of arterial aneurysm and dissection, every patient diagnosed with FMD should have one-time, head-to-pelvic cross-sectional imaging. The preferred imaging strategy is CTA, with MRA as an alternative.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The conditions that most commonly mimic the presentation of FMD are atherosclerotic vascular disease and vasculitis. Patients with atherosclerosis are usually older and have typical cardiovascular risk factors, whereas individuals with FMD are usually younger and have fewer cardiovascular risk factors. Atherosclerosis usually involves the ostial or proximal segment of the arteries, whereas FMD involves the middle or distal segment; the "string of beads" appearance is also unique to FMD. Thus, atherosclerotic disease and FMD can typically be distinguished radiographically. Unlike patients with a vasculitic process, those with FMD generally will not have associated anemia, thrombocytopenia, or abnormalities of acute phase reactants (eg, erythrocyte sedimentation rate or C-reactive protein), given that it is a noninflammatory process. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who are treated medically (rather than with revascularization) should have monitoring of the blood pressure response to antihypertensive therapy and serum creatinine levels every three months. The decision against revascularization may need to change if hypertension is treatment resistant or if there is progressive loss of kidney function. Noninvasive imaging tests, such as duplex ultrasound, should be obtained every 6 to 12 months. Since radiation exposure is high, CTA should only be repeated if there is a strong clinical suspicion regarding the progression of the disease. If the patient has an aneurysm, they can be followed with MRA to follow the size of the aneurysm. (See
         <a class="local">
          'Monitoring disease progression'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med 2019; 24:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012; 125:3182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plouin PF, Baguet JP, Thony F, et al. High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia). Hypertension 2017; 70:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg 2011; 53:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014; 129:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green R, Gu X, Kline-Rogers E, et al. Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry. Pediatr Nephrol 2016; 31:641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang YY, Chen Y, Wu QH, et al. Prevalence and clinical characteristics of renovascular hypertension associated with fibromuscular dysplasia in China. J Hypertens 2023; 41:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shivapour DM, Erwin P, Kim ESh. Epidemiology of fibromuscular dysplasia: A review of the literature. Vasc Med 2016; 21:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persu A, Van der Niepen P, Touzé E, et al. Revisiting Fibromuscular Dysplasia: Rationale of the European Fibromuscular Dysplasia Initiative. Hypertension 2016; 68:832.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savard S, Steichen O, Azarine A, et al. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation 2012; 126:3062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piercy KT, Hundley JC, Stafford JM, et al. Renovascular disease in children and adolescents. J Vasc Surg 2005; 41:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kløw NE, Paulsen D, Vatne K, et al. Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients. Acta Radiol 1998; 39:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pascual A, Bush HS, Copley JB. Renal fibromuscular dysplasia in elderly persons. Am J Kidney Dis 2005; 45:e63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plouin PF, Perdu J, La Batide-Alanore A, et al. Fibromuscular dysplasia. Orphanet J Rare Dis 2007; 2:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendricks NJ, Matsumoto AH, Angle JF, et al. Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates. Vasc Med 2014; 19:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350:1862.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mettinger KL. Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke 1982; 13:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 1982; 13:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lather HD, Gornik HL, Olin JW, et al. Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia. JAMA Neurol 2017; 74:1081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           UCAS Japan Investigators, Morita A, Kirino T, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012; 366:2474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cloft HJ, Kallmes DF, Kallmes MH, et al. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg 1998; 88:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brinza E, Grabinski V, Durga S, et al. Lower Extremity Fibromuscular Dysplasia: Clinical Manifestations, Diagnostic Testing, and Approach to Management. Angiology 2017; 68:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen N, Sharma A, West JK, et al. Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia. J Vasc Surg 2017; 66:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanley JC, Gewertz BL, Bove EL, et al. Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg 1975; 110:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971; 46:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW. Is fibromuscular dysplasia a single disease? Circulation 2012; 126:2925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persu A, Dobrowolski P, Gornik HL, et al. Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia. Cardiovasc Res 2022; 118:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perdu J, Boutouyrie P, Bourgain C, et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens 2007; 21:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ganesh SK, Morissette R, Xu Z, et al. Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB J 2014; 28:3313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiando SR, Tucker NR, Castro-Vega LJ, et al. PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance. PLoS Genet 2016; 12:e1006367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Debette S, Kamatani Y, Metso TM, et al. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat Genet 2015; 47:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adlam D, Olson TM, Combaret N, et al. Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection. J Am Coll Cardiol 2019; 73:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Georges A, Albuisson J, Berrandou T, et al. Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia. Cardiovasc Res 2021; 117:1154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW, Di Narzo AF, d'Escamard V, et al. A plasma proteogenomic signature for fibromuscular dysplasia. Cardiovasc Res 2020; 116:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim ES, Olin JW, Froehlich JB, et al. Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol 2013; 62:2026.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Touzé E, Southerland AM, Boulanger M, et al. Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review. JAMA Neurol 2019; 76:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kadian-Dodov D, Gornik HL, Gu X, et al. Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD. J Am Coll Cardiol 2016; 68:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Touzé E, Oppenheim C, Trystram D, et al. Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke 2010; 5:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Debette S, Grond-Ginsbach C, Bodenant M, et al. Differential features of carotid and vertebral artery dissections: the CADISP study. Neurology 2011; 77:1174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guill CK, Benavides DC, Rees C, et al. Fatal mesenteric fibromuscular dysplasia: a case report and review of the literature. Arch Intern Med 2004; 164:1148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW, Kadian-Dodov D. Exercise-induced leg pain and high blood pressure. JAMA 2014; 311:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kadian-Dodov D, Goldfinger JZ, Gustavson S, Olin JW. Natural History of Cervical Artery Fibromuscular Dysplasia and Associated Neurovascular Events. Cerebrovasc Dis 2018; 46:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tweet MS, Hayes SN, Pitta SR, et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation 2012; 126:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saw J, Humphries K, Aymong E, et al. Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence. J Am Coll Cardiol 2017; 70:1148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tweet MS, Olin JW. Insights Into Spontaneous Coronary Artery Dissection: Can Recurrence Be Prevented? J Am Coll Cardiol 2017; 70:1159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tweet MS, Gulati R, Williamson EE, et al. Multimodality Imaging for Spontaneous Coronary Artery Dissection in Women. JACC Cardiovasc Imaging 2016; 9:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saw J, Bezerra H, Gornik HL, et al. Angiographic and Intracoronary Manifestations of Coronary Fibromuscular Dysplasia. Circulation 2016; 133:1548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saw J, Starovoytov A, Aymong E, et al. Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes. J Am Coll Cardiol 2022; 80:1585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelis KC, Olin JW, Kadian-Dodov D, et al. Coronary artery manifestations of fibromuscular dysplasia. J Am Coll Cardiol 2014; 64:1033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayes SN, Tweet MS, Adlam D, et al. Spontaneous Coronary Artery Dissection: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 76:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bolen MA, Brinza E, Renapurkar RD, et al. Screening CT Angiography of the Aorta, Visceral Branch Vessels, and Pelvic Arteries in Fibromuscular Dysplasia. JACC Cardiovasc Imaging 2017; 10:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW, Kadian-Dodov D. Fibromuscular Dysplasia: Looking Beyond the "String of Beads". JACC Cardiovasc Imaging 2017; 10:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warchol-Celinska E, Prejbisz A, Dobrowolski P, et al. Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions: The ARCADIA-POL Study. Hypertension 2020; 75:1102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sethi SS, Lau JF, Godbold J, et al. The S curve: a novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia. Vasc Med 2014; 19:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olin JW, Piedmonte MR, Young JR, et al. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995; 122:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004; 141:674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gowda MS, Loeb AL, Crouse LJ, Kramer PH. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the "gold standard"? J Am Coll Cardiol 2003; 41:1305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sabharwal R, Vladica P, Coleman P. Multidetector spiral CT renal angiography in the diagnosis of renal artery fibromuscular dysplasia. Eur J Radiol 2007; 61:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Funabashi N, Komiyama N, Komuro I. Fibromuscular dysplasia in renovascular hypertension demonstrated by multislice CT: comparison with conventional angiogram and intravascular ultrasound. Heart 2003; 89:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cadour F, Silhol F, Iline N, et al. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study. J Vasc Surg 2022; 75:939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narula N, Kadian-Dodov D, Olin JW. Fibromuscular Dysplasia: Contemporary Concepts and Future Directions. Prog Cardiovasc Dis 2018; 60:580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mounier-Vehier C, Lions C, Jaboureck O, et al. Parenchymal consequences of fibromuscular dysplasia renal artery stenosis. Am J Kidney Dis 2002; 40:1138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mounier-Véhier C, Haulon S, Devos P, et al. Renal atrophy outcome after revascularization in fibromuscular dysplasia disease. J Endovasc Ther 2002; 9:605.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3874 Version 28.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30648921" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : First International Consensus on the diagnosis and management of fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22615343" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28716989" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21236620" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Diagnosis, management, and future developments of fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24548843" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26525198" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36723459" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Prevalence and clinical characteristics of renovascular hypertension associated with fibromuscular dysplasia in China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27067138" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Epidemiology of fibromuscular dysplasia: A review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27504007" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Revisiting Fibromuscular Dysplasia: Rationale of the European Fibromuscular Dysplasia Initiative.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23155180" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15944596" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Renovascular disease in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9817028" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15806462" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Renal fibromuscular dysplasia in elderly persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17555581" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25082538" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15115832" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7039003" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Fibromuscular dysplasia and the brain. II. Current concept of the disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7064180" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28715558" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22738097" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The natural course of unruptured cerebral aneurysms in a Japanese cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9488296" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28006960" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Lower Extremity Fibromuscular Dysplasia: Clinical Manifestations, Diagnostic Testing, and Approach to Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28735951" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1131001" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Arterial fibrodysplasia. Histopathologic character and current etiologic concepts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5553126" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Pathologic classification of renal arterial disease in renovascular hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23248062" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Is fibromuscular dysplasia a single disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33739371" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17330059" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Inheritance of arterial lesions in renal fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24732132" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-βexpression and connective tissue features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27792790" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25420145" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30621952" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32531060" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31424497" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : A plasma proteogenomic signature for fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23954333" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30285053" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27386771" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20636713" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Fibromuscular dysplasia of cervical and intracranial arteries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21900632" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Differential features of carotid and vertebral artery dissections: the CADISP study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15159274" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Fatal mesenteric fibromuscular dysplasia: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24449320" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Exercise-induced leg pain and high blood pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30064124" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Natural History of Cervical Artery Fibromuscular Dysplasia and Associated Neurovascular Events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22800851" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Clinical features, management, and prognosis of spontaneous coronary artery dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838364" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838365" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Insights Into Spontaneous Coronary Artery Dissection: Can Recurrence Be Prevented?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27056163" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Multimodality Imaging for Spontaneous Coronary Artery Dissection in Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26957531" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Angiographic and Intracoronary Manifestations of Coronary Fibromuscular Dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36265953" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25190240" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Coronary artery manifestations of fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32819471" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Spontaneous Coronary Artery Dissection: JACC State-of-the-Art Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27665159" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Screening CT Angiography of the Aorta, Visceral Branch Vessels, and Pelvic Arteries in Fibromuscular Dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27665162" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Fibromuscular Dysplasia: Looking Beyond the "String of Beads".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32148126" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions: The ARCADIA-POL Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25135311" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The S curve: a novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7741367" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15520423" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12706925" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the "gold standard"?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17097843" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Multidetector spiral CT renal angiography in the diagnosis of renal artery fibromuscular dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12748219" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Fibromuscular dysplasia in renovascular hypertension demonstrated by multislice CT: comparison with conventional angiogram and intravascular ultrasound.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34601043" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29534984" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Fibromuscular Dysplasia: Contemporary Concepts and Future Directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12460031" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Parenchymal consequences of fibromuscular dysplasia renal artery stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12431144" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Renal atrophy outcome after revascularization in fibromuscular dysplasia disease.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
